Riverbridge Partners’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-92,494
Closed -$4.77M 203
2026
Q1
$4.77M Sell
92,494
-4,617
-5% -$323K 0.12% 93
2025
Q4
$8.96M Sell
97,111
-6,460
-6% -$618K 0.17% 91
2025
Q3
$7.68M Sell
103,571
-10,315
-9% -$1.04M 0.13% 92
2025
Q2
$14.8M Sell
113,886
-18,505
-14% -$2.68M 0.24% 85
2025
Q1
$21.1M Sell
132,391
-9,706
-7% -$1.76M 0.34% 79
2024
Q4
$26.3M Buy
+142,097
New +$27.6M 0.36% 78

Other funds holding INSP

Riverbridge Partners's INSP Position: Q2 2026 in Review

Riverbridge Partners sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 92,494 shares — an estimated $4.77M sold.

Riverbridge Partners first reported a position in INSP in Q4 2024 and held it in 6 quarters. The position peaked at $26.3M in Q4 2024. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Riverbridge Partners reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
  • Riverbridge Partners sold 92,494 Inspire Medical Systems shares in Q2 2026, an estimated $4.77M.
  • Riverbridge Partners first reported a position in Inspire Medical Systems in Q4 2024 and held it in 6 quarters.
  • Riverbridge Partners's Inspire Medical Systems position peaked at $26.3M in Q4 2024.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Riverbridge Partners's 13F filing for Q2 2026, filed 13 Jul 2026.